Identification of the best cutoff points and clinical signs specific for early recognition of macrophage activation syndrome in active systemic juvenile idiopathic arthritis

Seminars in Arthritis and Rheumatism

Volumn 44, Issue 4, 2015, Pages 417-422

  Kostik, Mikhail M ^a   Dubko, Margarita F ^a   Masalova, Vera V ^a   Snegireva, Ludmila S ^a   Kornishina, Tatyana L ^a   Chikova, Irina A ^a   Likhacheva, Tatyana S ^a   Isupova, Eugenia A ^a   Glebova, Natalia I ^a   Kuchinskaya, Ekaterina M ^a   Balbotkina, Eugenia V ^a   Buchinskaya, Natalia V ^a   Kalashnikova, Olga V ^a   Chasnyk, Vyacheslav G ^a  

^a SAINT PETERSBURG STATE PEDIATRIC MEDICAL UNIVERSITY   (Russian Federation)

Author keywords

Macrophage activation syndrome (MAS); Systemic juvenile idiopathic arthritis

Indexed keywords

ALBUMIN; ASPARTATE AMINOTRANSFERASE; FERRITIN; FIBRINOGEN; LACTATE DEHYDROGENASE; BIOLOGICAL MARKER;

ARTICLE; BLEEDING; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE CLASSIFICATION; DISEASE COURSE; FEMALE; HUMAN; JUVENILE RHEUMATOID ARTHRITIS; LABORATORY DIAGNOSIS; LEUKOCYTE COUNT; MACROPHAGE ACTIVATION SYNDROME; MALE; MEDICAL RECORD REVIEW; PRIORITY JOURNAL; PROTEINURIA; PROXIMAL INTERPHALANGEAL JOINT; RESPIRATORY FAILURE; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SPLENOMEGALY; THROMBOCYTE COUNT; WRIST DISEASE; ARTHRITIS, JUVENILE; BLOOD; COMPLICATION; DIFFERENTIAL DIAGNOSIS; EARLY DIAGNOSIS; HEMORRHAGE; INFANT; METABOLISM; PRESCHOOL CHILD; RESPIRATORY INSUFFICIENCY; RETROSPECTIVE STUDY;

ARTHRITIS, JUVENILE; BIOLOGICAL MARKERS; CHILD; CHILD, PRESCHOOL; DIAGNOSIS, DIFFERENTIAL; EARLY DIAGNOSIS; FEMALE; FERRITINS; FIBRINOGEN; HEMORRHAGE; HUMANS; INFANT; L-LACTATE DEHYDROGENASE; LEUKOCYTE COUNT; MACROPHAGE ACTIVATION SYNDROME; MALE; RESPIRATORY INSUFFICIENCY; RETROSPECTIVE STUDIES; RISK FACTORS; SPLENOMEGALY;

EID: 84927693478     PISSN: 00490172     EISSN: 1532866X     Source Type: Journal    
DOI: 10.1016/j.semarthrit.2014.09.004     Document Type: Article

References (32)

1. Prieur A.M., Stephan J.L. Macrophage activation syndrome in rheumatic diseases in children. Rev Rhum Ed Fr 1994, 61:447-451.
2. Behrens E.M., Beukelman T., Paessler M., Cron R.Q. Occult macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis. J Rheumatol 2007, 34:1133-1138.
3. Bleesing J., Prada A., Siegel D.M., Villanueva J., Olson J., Ilowite N.T., et al. The diagnostic significance of soluble CD163 and soluble interleukin-2 receptor alpha-chain in macrophage activation syndrome and untreated new-onset systemic juvenile idiopathic arthritis. Arthritis Rheum 2007, 56:965-971.
4. Kelly A., Ramanan A.V. Recognition and management of macrophage activation syndrome in juvenile arthritis. Curr Opin Rheumatol 2007, 19:477-481.
5. Filipovich A.H. Hemophagocytic lymphohistiocytosis (HLH) and related disorders. Hematology Am Soc Hematol Educ Program 2009, 127-131.
6. Favara B.E., Feller A.C., Pauli M., Jaffe E.S., Weiss L.M., Arico M., et al. Contemporary classification of histiocytic disorders. The WHO Committee on Histiocytic/Reticulum Cell Proliferations. Reclassification Working Group of the Histiocyte Society. Med Pediatr Oncol 1997, 29:157-166.
7. Tristano A.G., Casanova-Escalona L., Torres A., Rodriguez M.A. Macrophage activation syndrome in a patient with systemic onset rheumatoid arthritis: rescue with intravenous immunoglobulin therapy. J Clin Rheumatol 2003, 9:253-258.
8. Miettunen P.M., Narendran A., Jayanthan A., Behrens E.M., Cron R.Q. Successful treatment of severe paediatric rheumatic disease-associated macrophage activation syndrome with interleukin-1 inhibition following conventional immunosuppressive therapy: case series with 12 patients. Rheumatology (Oxford) 2011, 50:417-419.
9. Bruck N., Suttorp M., Kabus M., Heubner G., Gahr M., Pessler F. Rapid and sustained remission of systemic juvenile idiopathic arthritis-associated macrophage activation syndrome through treatment with anakinra and corticosteroids. J Clin Rheumatol 2011, 17:23-27.
10. Kelly A., Ramanan A.V. A case of macrophage activation syndrome successfully treated with anakinra. Nat Clin Pract Rheumatol 2008, 4:615-620.
11. Zhang K., Jordan M.B., Marsh R.A., Johnson J.A., Kissell D., Meller J., et al. Hypomorphic mutations in PRF1, MUNC13-4, and STXBP2 are associated with adult-onset familial hemophagocytic lymphohistiocytosis. Blood 2011, 118:5794-5798.
12. Sullivan K.E., Delaat C.A., Douglas S.D., Filipovich A.H. Defective natural killer cell function in patients with hemophagocytic lymphohistiocytosis and in first degree relatives. Pediatr Res 1998, 44:465-468.
13. Feldmann J., Callebaut I., Raposo G., Certain S., Bacq D., Dumont C., et al. Munc13-4 is essential for cytolytic granules fusion and is mutated in a form of familial hemophagocytic lymphohistiocytosis (FHL3). Cell 2003, 115:461-473.
14. Stepp S.E., Dufourcq-Lagelouse R., Le Deist F., Bhawan S., Certain S., Mathew P.A., et al. Perforin gene defects in familial hemophagocytic lymphohistiocytosis. Science 1999, 286:1957-1959.
15. zur Stadt U., Rohr J., Seifert W., Koch F., Grieve S., Pagel J., et al. Familial hemophagocytic lymphohistiocytosis type 5 (FHL-5) is caused by mutations in Munc18-2 and impaired binding to syntaxin 11. Am J Hum Genet 2009, 85:482-492.
16. zur Stadt U., Schmidt S., Kasper B., Beutel K., Diler A.S., Henter J.I., et al. Linkage of familial hemophagocytic lymphohistiocytosis (FHL) type-4 to chromosome 6q24 and identification of mutations in syntaxin 11. Hum Mol Genet 2005, 14:827-834.
17. Brown D.E., McCoy M.W., Pilonieta M.C., Nix R.N., Detweiler C.S. Chronic murine typhoid fever is a natural model of secondary hemophagocytic lymphohistiocytosis. PLoS One 2010, 5:e9441.
18. Yanagimachi M., Naruto T., Miyamae T., Hara T., Kikuchi M., Hara R., et al. Association of IRF5 polymorphisms with susceptibility to macrophage activation syndrome in patients with juvenile idiopathic arthritis. J Rheumatol 2011, 38:769-774.
19. Behrens E.M., Canna S.W., Slade K., Rao S., Kreiger P.A., Paessler M., et al. Repeated TLR9 stimulation results in macrophage activation syndrome-like disease in mice. J Clin Invest 2011, 121:2264-2277.
20. Fife M.S., Gutierrez A., Ogilvie E.M., Stock C.J., Samuel J.M., Thomson W., et al. Novel IL10 gene family associations with systemic juvenile idiopathic arthritis. Arthritis Res Ther 2006, 8:R148.
21. Moller J.C., Paul D., Ganser G., Range U., Gahr M., Kelsch R., et al. IL10 promoter polymorphisms are associated with systemic onset juvenile idiopathic arthritis (SoJIA). Clin Exp Rheumatol 2010, 28:912-918.
22. Henter J.I., Horne A., Aricó M., Egeler R.M., Filipovich A.H., Imashuku S., et al. HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer 2007, 48:124-131.
23. Stephan J.-L., Koned-Paut I., Galanbrun C., Mouy R., Bader-Meunier B., Prieur A.-M. Reactive haemophagocytic syndrome in children with inflammatory disorders: a retrospective study of 24 patients. Rheumatology 2001, 40:1285-1292.
24. Ravelli A., Magni-Manzoni S., Pistorio A., Besana C., Foti T., Ruperto N., et al. Preliminary diagnostic guidelines for macrophage activation syndrome complicating systemic juvenile idiopathic arthritis. J Pediatr 2005, 146:598-604.
25. Davì S.1, Consolaro A., Guseinova D., Pistorio A., Ruperto N., Martini A., et al. An international consensus survey of diagnostic criteria for macrophage activation syndrome in systemic juvenile idiopathic arthritis. J Rheumatol 2011, 38:764-768.
26. Petty R.E., Southwood T.R., Manners P., Baum J., Glass D.N., Goldenberg J., et al. International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton 2001. J Rheumatol 2004, 31:390-392.
27. Ravelli A. Macrophage activation syndrome. Curr Opin Rheumatol 2002, 14:548-552.
28. Ravelli A., Grom A.A., Behrens E.M., Cron R.Q. Macrophage activation syndrome as part of systemic juvenile idiopathic arthritis: diagnosis, genetics, pathophysiology and treatment. Genes Immun 2012, 13:289-298.
29. Parodi A., Davi S., Pringe A.B., Pistorio A., Ruperto N., Magni-Manzoni S., et al. Macrophage activation syndrome in juvenile systemic lupus erythematosus: a multinational multicenter study of thirty-eight patients. Arthritis Rheum 2009, 60:3388-3399.
30. Rigante D., Capoluongo E., Bertoni B., Ansuini V., Chiaretti A., Piastra M., et al. First report of macrophage activation syndrome in hyperimmunoglobulinemia D with periodic fever syndrome. Arthritis Rheum 2007, 56:658-661.
31. de Jager W., Vastert S.J., Beekman J.M., Wulffraat N.M., Kuis W., Coffer P.J., et al. Defective phosphorylation of interleukin-18 receptor beta causes impaired natural killer cell function in systemic-onset juvenile idiopathic arthritis. Arthritis Rheum 2009, 60:2782-2793.
32. Zhou J., Tang X., Ding Y., An Y., Zhao X. Natural killer cell activity and frequency of killer cell immunoglobulin-like receptors in children with different forms of juvenile idiopathic arthritis. Pediatr Allergy Immunol 2013, 24:691-696.